Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

SHE:300534 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Revenue Revenue Growth	709.93	886.96	1,043	1,080	799.68	287.81
Revenue Growth	-21.41%	-14.92%	-3.48%	35.06%	177.85%	12.91%
Gross Profit Gross Profit Growth	465.3	603.55	751.13	693.26	458.06	92.33
Operating Income Operating Income Growth	57.4	87.47	96.02	81.82	56.31	-9.31
Net Income Net Income Growth	24.75	43.95	24.48	61.65	38.79	-9.11
Earnings Per Share EPS Growth	0.08	0.14	0.08	0.20	0.13	-0.03
EPS Growth	14.22%	79.55%	-60.28%	58.87%	-	-

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
China China Growth	874.83	1,034	1,071	789.4	275.55
Foreign Foreign Growth	12.13	8.4	8.63	10.28	12.26
Total Total Growth	886.96	1,043	1,080	799.68	287.81

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Investments Cash & Investments Growth	210.76	241.33	310.02	288.95	369.24	99.12
Total Debt Total Debt Growth	139.25	132.51	114.68	144.54	-	-
Net Cash (Debt) Net Cash Growth	71.51	108.82	195.34	144.4	369.24	99.12
Net Cash Growth	50.09%	-44.29%	35.27%	-60.89%	272.52%	105.97%
Net Cash Per Share Net Cash Per Share Growth	0.24	0.36	0.64	0.48	1.22	0.33

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Cash Flow Operating Cash Flow Growth	92.46	-6.54	214.92	96.53	267.44	51.13
Capital Expenditures CapEx Growth	-27.66	-43.36	-77.69	-126.36	-25.41	-0.41
Free Cash Flow Free Cash Flow Growth	64.81	-49.9	137.23	-29.83	242.03	50.72
Free Cash Flow Growth	-	-	-	-	377.18%	103.30%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Gross Margin	65.54%	68.05%	72.05%	64.19%	57.28%	32.08%
Operating Margin	8.09%	9.86%	9.21%	7.58%	7.04%	-3.24%
Pretax Margin	9.49%	9.15%	9.76%	8.98%	8.27%	-1.65%
Profit Margin	3.49%	4.96%	2.35%	5.71%	4.85%	-3.16%
FCF Margin	9.13%	-5.63%	13.16%	-2.76%	30.27%	17.62%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Dividend Per Share Dividend Per Share Growth	0.040	0.040	0.040	0.020
Dividend Per Share Growth	0%	0%	100.00%	-
Dividend Yield	0.39%	0.42%	0.46%	0.20%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 24, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	125.44	65.43	107.82	48.57	69.37	-
P/FCF Ratio	47.89	-	19.23	-	11.12	88.04
PS Ratio	4.37	3.24	2.53	2.77	3.37	15.51

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error